subject: UNII:B72HH48FLU

subject_name: Infliximab


subject: UNII:B72HH48FLU

object_name: lymphocyte count

tested_intervention: unsure


subject: CHEBI:6775

subject_name: Mesalazine

object_name: colitis


subject: CHEBI:6775

object_name: Colitis, CTCAE


subject: CHEBI:6775

object_name: Hermansky-Pudlak syndrome


subject: CHEBI:6775


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: UMLS:C5418072

subject_name: Anti-CD47 Monoclonal Antibody IMC-002

object_name: Childhood Solid Neoplasm

tested_intervention: yes


subject: UMLS:C5418072

object_name: Adult Solid Neoplasm


subject: UMLS:C5418072

object_name: Solid Neoplasm


subject: UMLS:C5418072

object_name: adult lymphoma


subject: UMLS:C5418072

object_name: lymphoma


subject: UMLS:C5418072

object_name: pediatric lymphoma


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: small intestine cancer


subject: CHEBI:201431

object_name: small intestine carcinoma


subject: CHEBI:201431

object_name: Drug toxicity


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881

object_name: leukopenia


subject: CHEBI:90881

object_name: neutropenia


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:8069

subject_name: Phenobarbital


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8069

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:94686

subject_name: Orlistat

object_name: lung adenocarcinoma


subject: CHEBI:95021

subject_name: pemetrexed

object_name: Effects of chemotherapy


subject: CHEBI:63724


subject: UMLS:C0939898

subject_name: Cannabis Preparation

object_name: cannabis abuse


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: multiple sclerosis


subject: CHEBI:26710

object_name: chronic progressive multiple sclerosis


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Surgical procedure finding


subject: UMLS:C5238055

subject_name: Tengonermin

object_name: liver carcinoma


subject: UMLS:C1143119

subject_name: Zafiride


subject: CHEBI:95341

subject_name: Baricitinib

object_name: polymyalgia rheumatica


subject: UNII:2261HH611H

subject_name: Tenalisib

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab

object_name: nodular lymphocyte predominant Hodgkin lymphoma


subject: UNII:LDJ89SS0YG

object_name: Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma


subject: UNII:LDJ89SS0YG

object_name: Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C0112695

subject_name: Decadron phosphate

object_name: lumbar spinal stenosis


subject: UMLS:C0112695

object_name: spinal stenosis


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: CHEBI:145365

subject_name: Crenolanib

object_name: glioma


subject: CHEBI:145365

object_name: malignant glioma


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: temporomandibular joint disorder


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: Flail Chest


subject: CHEBI:35475

object_name: Fractured rib


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C0003211


subject: UMLS:C3536840

subject_name: Nonsteroidal Anti-inflammatory Drug [EPC]

object_name: Physical trauma


subject: UMLS:C3536840

object_name: Injury


subject: UMLS:C3536840

object_name: Trauma


subject: UMLS:C3536840


subject: UMLS:C3536840


subject: PUBCHEM.COMPOUND:126961754

subject_name: Opioids


subject: PUBCHEM.COMPOUND:126961754


subject: PUBCHEM.COMPOUND:126961754


subject: PUBCHEM.COMPOUND:126961754


subject: PUBCHEM.COMPOUND:126961754


subject: PUBCHEM.COMPOUND:126961754

object_name: Surgical procedure finding


subject: CHEBI:35482

subject_name: opioid analgesic


subject: CHEBI:35482


subject: CHEBI:35482


subject: CHEBI:35482


subject: CHEBI:35482


subject: CHEBI:35482


subject: UMLS:C0242402


subject: UMLS:C0242402


subject: UMLS:C0242402


subject: UMLS:C0242402


subject: UMLS:C0242402


subject: UMLS:C0242402


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:46195


subject: CHEBI:46195


subject: CHEBI:46195


subject: CHEBI:46195


subject: UMLS:C3642745

subject_name: ketamine topical

object_name: head and neck cancer


subject: UMLS:C3642745

object_name: Pharyngeal Mucositis


subject: UMLS:C3642745

object_name: Pharyngeal Mucositis, CTCAE


subject: UMLS:C3642745

object_name: stomatitis


subject: UMLS:C3642745

object_name: Mucositis Oral, CTCAE


subject: UMLS:C4527230

subject_name: Zirconium (89Zr) crefmirlimab berdoxam

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: uterine fibroid


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Infection


subject: CHEBI:74705

object_name: Infection of musculoskeletal system


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: UMLS:C4721638

subject_name: Co-trimoxazole 960mg dispersible tablet

object_name: Primary bacterial peritonitis


subject: UMLS:C4721638

object_name: acute spontaneous bacterial peritonitis


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate


subject: CHEBI:119915

subject_name: Fentanyl

object_name: osteoarthritis


subject: UMLS:C4745006

object_name: neoplasm


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Irreversible pulpitis


subject: CHEBI:17688

subject_name: Nicotine

object_name: Nicotine Addiction


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Muscle Invasive Bladder Carcinoma


subject: UNII:28X28X9OKV

object_name: Stage II Bladder Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IIIA Bladder Cancer AJCC v8


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:4B93MGE4AL

subject_name: Futibatinib


subject: UNII:4B93MGE4AL


subject: UNII:4B93MGE4AL


subject: UNII:4B93MGE4AL

object_name: bladder transitional cell carcinoma


subject: UNII:4B93MGE4AL

object_name: transitional cell carcinoma


subject: UMLS:C3896647

subject_name: Miracle Mouthwash Plus Hydrocortisone

object_name: stomatitis


subject: UMLS:C3896647

object_name: breast neoplasm


subject: UMLS:C3896647

object_name: Oral Mucositis


subject: UMLS:C3896647

object_name: oral mucositis


subject: UMLS:C3896647

object_name: breast cancer


subject: CHEBI:3213

subject_name: Bumetanide

object_name: Cirrhosis


subject: CHEBI:3213

object_name: liver cirrhosis


subject: CHEBI:47426

subject_name: Furosemide


subject: CHEBI:88464

subject_name: (9E,11E)-octadecadienoic acid

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:36025

subject_name: octadeca-9,11-dienoic acid


subject: CHEBI:61159

subject_name: conjugated linoleic acid


subject: MESH:D044243

subject_name: Linoleic Acids, Conjugated


subject: CHEBI:41791

subject_name: calyculin A


subject: CHEBI:3732

subject_name: Clarithromycin


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: B-Cell Leukemia


subject: CHEBI:70839

subject_name: Dasatinib

object_name: acute leukemia


subject: CHEBI:70839


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:84040

object_name: Rectal cancer stage I


subject: CHEBI:84040

object_name: Stage I Rectal Cancer AJCC v6 and v7


subject: CHEBI:84040

object_name: Stage I Rectal Cancer AJCC v8


subject: CHEBI:84040

object_name: Stage II Rectal Cancer AJCC v7


subject: CHEBI:84040

object_name: Stage II Rectal Cancer AJCC v8


subject: CHEBI:84040

object_name: Stage II Rectal Cancer


subject: CHEBI:84040

object_name: Stage III Rectal Cancer AJCC v6


subject: CHEBI:84040

object_name: Stage III Rectal Cancer AJCC v7


subject: CHEBI:84040

object_name: Stage III Rectal Cancer AJCC v8


subject: CHEBI:84040

object_name: Carcinoma of colon, stage I


subject: CHEBI:84040

object_name: Stage I Colon Cancer AJCC v6 and v7


subject: CHEBI:84040

object_name: Stage I Colon Cancer AJCC v8


subject: CHEBI:84040

object_name: colon adenocarcinoma


subject: CHEBI:84040

object_name: rectum adenocarcinoma


subject: CHEBI:84040

object_name: Stage II Colon Cancer AJCC v8


subject: CHEBI:84040

object_name: Stage II Colon Cancer AJCC v7


subject: CHEBI:84040

object_name: Stage II Colon Cancer


subject: CHEBI:84040

object_name: Stage III Colon Cancer AJCC v7


subject: CHEBI:84040

object_name: Stage III Colon Cancer AJCC v8


subject: CHEBI:84040

object_name: Stage III Colon Cancer


subject: CHEBI:36002

subject_name: cis-resveratrol

object_name: Rectal cancer stage I


subject: CHEBI:36002

object_name: Stage I Rectal Cancer AJCC v6 and v7


subject: CHEBI:36002

object_name: Stage I Rectal Cancer AJCC v8


subject: CHEBI:36002

object_name: Stage II Rectal Cancer AJCC v7


subject: CHEBI:36002

object_name: Stage II Rectal Cancer AJCC v8


subject: CHEBI:36002

object_name: Stage II Rectal Cancer


subject: CHEBI:36002

object_name: Stage III Rectal Cancer AJCC v6


subject: CHEBI:36002

object_name: Stage III Rectal Cancer AJCC v7


subject: CHEBI:36002

object_name: Stage III Rectal Cancer AJCC v8


subject: CHEBI:36002

object_name: Carcinoma of colon, stage I


subject: CHEBI:36002

object_name: Stage I Colon Cancer AJCC v6 and v7


subject: CHEBI:36002

object_name: Stage I Colon Cancer AJCC v8


subject: CHEBI:36002

object_name: colon adenocarcinoma


subject: CHEBI:36002

object_name: rectum adenocarcinoma


subject: CHEBI:36002

object_name: Stage II Colon Cancer AJCC v8


subject: CHEBI:36002

object_name: Stage II Colon Cancer AJCC v7


subject: CHEBI:36002

object_name: Stage II Colon Cancer


subject: CHEBI:36002

object_name: Stage III Colon Cancer AJCC v7


subject: CHEBI:36002

object_name: Stage III Colon Cancer AJCC v8


subject: CHEBI:36002

object_name: Stage III Colon Cancer


subject: CHEBI:27881

subject_name: resveratrol

object_name: Rectal cancer stage I


subject: CHEBI:27881

object_name: Stage I Rectal Cancer AJCC v6 and v7


subject: CHEBI:27881

object_name: Stage I Rectal Cancer AJCC v8


subject: CHEBI:27881

object_name: Stage II Rectal Cancer AJCC v7


subject: CHEBI:27881

object_name: Stage II Rectal Cancer AJCC v8


subject: CHEBI:27881

object_name: Stage II Rectal Cancer


subject: CHEBI:27881

object_name: Stage III Rectal Cancer AJCC v6


subject: CHEBI:27881

object_name: Stage III Rectal Cancer AJCC v7


subject: CHEBI:27881

object_name: Stage III Rectal Cancer AJCC v8


subject: CHEBI:27881

object_name: Carcinoma of colon, stage I


subject: CHEBI:27881

object_name: Stage I Colon Cancer AJCC v6 and v7


subject: CHEBI:27881

object_name: Stage I Colon Cancer AJCC v8


subject: CHEBI:27881

object_name: colon adenocarcinoma


subject: CHEBI:27881

object_name: rectum adenocarcinoma


subject: CHEBI:27881

object_name: Stage II Colon Cancer AJCC v8


subject: CHEBI:27881

object_name: Stage II Colon Cancer AJCC v7


subject: CHEBI:27881

object_name: Stage II Colon Cancer


subject: CHEBI:27881

object_name: Stage III Colon Cancer AJCC v7


subject: CHEBI:27881

object_name: Stage III Colon Cancer AJCC v8


subject: CHEBI:27881

object_name: Stage III Colon Cancer


subject: CHEBI:6121

subject_name: Ketamine

object_name: biopsy characteristics


subject: CHEBI:87631

subject_name: statin

object_name: Klatskin Tumor


subject: CHEBI:9150

subject_name: Simvastatin


subject: DRUGBANK:DB19249

subject_name: Bos taurus colostrum

object_name: Immunity, Innate


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: urinary bladder carcinoma


subject: CHEBI:194095

object_name: urinary bladder cancer


subject: CHEBI:194095

object_name: childhood bladder carcinoma


subject: CHEBI:229599

subject_name: Trofinetide

object_name: brain injury


subject: UMLS:C2715489


subject: CHEBI:63610

subject_name: Misoprostol

object_name: fetus or newborn; effects of induction of labor


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: asthma


subject: CHEBI:61057

object_name: inherited susceptibility to asthma


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:46195

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: alcoholic hepatitis


subject: CHEBI:51254

object_name: alcoholic liver diseases


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:71013

subject_name: Perampanel

object_name: Lennox-Gastaut syndrome


subject: UMLS:C2985190

subject_name: Liposomal Docetaxel

object_name: prostate carcinoma


subject: UMLS:C2985190

object_name: prostate cancer


subject: UMLS:C0005525

subject_name: Biological Response Modifiers

object_name: Embolism, Tumor


subject: UMLS:C0876248

subject_name: Immunotherapeutic agent


subject: CHEBI:53210

subject_name: Levocarnitine propionate

object_name: Heart failure with normal ejection fraction


subject: CHEBI:15927

subject_name: Nicotinamide riboside


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Esophageal Squamous Cell Carcinoma by AJCC v8 Stage


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:5002

subject_name: Fenoldopam

object_name: Cardiac complication


subject: UNII:J27WDC343N

subject_name: MESOTHELIN

object_name: cancer


subject: UNII:J27WDC343N

object_name: neoplasm


subject: UNII:J27WDC343N

object_name: lung cancer


subject: UNII:J27WDC343N

object_name: lung neoplasm


subject: UNII:J27WDC343N

object_name: lung carcinoma


subject: PR:000001411

subject_name: CD276 molecule


subject: PR:000001411


subject: PR:000001411


subject: PR:000001411


subject: PR:000001411


subject: CHEBI:53287


subject: CHEBI:53287


subject: CHEBI:53287


subject: CHEBI:53287


subject: CHEBI:53287


subject: CHEBI:61370

subject_name: poly(stearyl methacrylate) polymer


subject: CHEBI:61370


subject: CHEBI:61370


subject: CHEBI:61370


subject: CHEBI:61370


subject: PUBCHEM.COMPOUND:155011957

subject_name: TGF-beta


subject: PUBCHEM.COMPOUND:155011957


subject: PUBCHEM.COMPOUND:155011957


subject: PUBCHEM.COMPOUND:155011957


subject: PUBCHEM.COMPOUND:155011957


subject: PR:000002082

subject_name: receptor tyrosine-protein kinase erbB-2


subject: PR:000002082


subject: PR:000002082


subject: PR:000002082


subject: PR:000002082


subject: UMLS:C0069515

subject_name: erbB-2 Receptor


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: CHEBI:88162


subject: CHEBI:88162


subject: CHEBI:88162


subject: CHEBI:88162


subject: CHEBI:88162


subject: CHEBI:62507


subject: CHEBI:62507


subject: CHEBI:62507


subject: CHEBI:62507


subject: CHEBI:62507


subject: CHEBI:59045


subject: CHEBI:59045


subject: CHEBI:59045


subject: CHEBI:59045


subject: CHEBI:59045


subject: UMLS:C5706286

subject_name: Jing Si Herbal Tea

object_name: airway disease


subject: CHEBI:45863

object_name: Refractory Primary Peritoneal Carcinoma


subject: CHEBI:45863

object_name: Refractory Ovarian Carcinoma


subject: CHEBI:45863

object_name: Refractory Fallopian Tube Carcinoma


subject: UMLS:C5706405

subject_name: Bcl-2 Inhibitor ABBV-453

object_name: Relapsed/refractory multiple myeloma


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: spondyloepimetaphyseal dysplasia, Strudwick type


subject: CHEBI:73604

object_name: spondylometaphyseal dysplasia


subject: CHEBI:73604

object_name: Stable Metabolic Disease


subject: CHEBI:4911

subject_name: Etoposide

object_name: head and neck squamous cell carcinoma


subject: PUBCHEM.COMPOUND:131751561

subject_name: Cyclostenol

object_name: dermatitis


subject: PUBCHEM.COMPOUND:131751561

object_name: Dermatitis


subject: DRUGBANK:DB14276

subject_name: Turmeric


subject: DRUGBANK:DB14276


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: PUBCHEM.COMPOUND:5281767


subject: UMLS:C4279748

object_name: Alzheimer disease type 1


subject: UNII:19FUJ2C58T

subject_name: Ginkgo biloba

object_name: multiple sclerosis


subject: UNII:19FUJ2C58T

object_name: INTELLIGENCE QUANTITATIVE TRAIT LOCUS 1


subject: UMLS:C3531686

subject_name: Ginkgo biloba whole extract


subject: UMLS:C3531686


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Cushing Disease


subject: CHEBI:4659

subject_name: Disulfiram

object_name: Drug-induced obesity


subject: UMLS:C5854539

subject_name: Anti-PD-L1/4-1BB Bispecific Antibody QLF31907

object_name: melanoma


subject: UMLS:C5854539

object_name: urothelial carcinoma


subject: UMLS:C5854539

object_name: transitional cell carcinoma


subject: CHEBI:87681

subject_name: Ranolazine

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:87681

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:87681

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:87681

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:87681

object_name: Stage IIA Prostate Cancer AJCC v7


subject: CHEBI:87681

object_name: Stage IIA Prostate Cancer AJCC v8


subject: CHEBI:87681

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:87681

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:87681

object_name: Carcinoma of the prostate stage III


subject: CHEBI:87681

object_name: Stage III Prostate Cancer AJCC v6


subject: CHEBI:87681

object_name: Stage IIB Prostate Cancer AJCC v8


subject: CHEBI:87681

object_name: Stage IIB Prostate Cancer AJCC v7


subject: CHEBI:87681

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:87681

object_name: prostate adenocarcinoma


subject: CHEBI:87681

object_name: Metastatic malignant neoplasm to soft tissues


subject: UMLS:C4521177

object_name: traumatic encephalopathy


subject: UMLS:C4521177

object_name: traumatic brain injury


subject: CHEBI:585948

subject_name: Felodipine

object_name: Disorder related to lung transplantation


subject: CHEBI:4653

subject_name: Dipyridamole

object_name: Endotoxemia


subject: CHEBI:168426

subject_name: ethyl citrate

object_name: colorectal neoplasm


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Metastatic Microsatellite Stable Colorectal Carcinoma


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UNII:12M44VTJ7B

subject_name: DALTEPARIN SODIUM

object_name: Diabetic foot ulcer


subject: UMLS:C0498888

subject_name: INJECTION, DALTEPARIN SODIUM, PER 2500 IU ADMINISTERED


subject: PUBCHEM.COMPOUND:69673196

subject_name: ALINTEGIMOD

object_name: Advanced cancer


subject: PUBCHEM.COMPOUND:69673196

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:69673196

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:69673196

object_name: Metastasis


subject: PUBCHEM.COMPOUND:69673196

object_name: Metastatic Lesion


subject: PUBCHEM.COMPOUND:69673196

object_name: skin neoplasm


subject: PUBCHEM.COMPOUND:69673196

object_name: skin cancer


subject: PUBCHEM.COMPOUND:69673196

object_name: renal carcinoma


subject: PUBCHEM.COMPOUND:69673196

object_name: kidney neoplasm


subject: PUBCHEM.COMPOUND:69673196

object_name: kidney cancer


subject: PUBCHEM.COMPOUND:69673196

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:69673196

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:69673196

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:69673196

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:69673196

object_name: renal cell adenocarcinoma


subject: PUBCHEM.COMPOUND:69673196

object_name: renal cell carcinoma


subject: PUBCHEM.COMPOUND:69673196

object_name: childhood kidney cell carcinoma


subject: PUBCHEM.COMPOUND:69673196

object_name: adult hepatocellular carcinoma


subject: PUBCHEM.COMPOUND:69673196

object_name: liver cancer


subject: PUBCHEM.COMPOUND:69673196

object_name: pediatric hepatocellular carcinoma


subject: PUBCHEM.COMPOUND:69673196

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:69673196

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:69673196

object_name: mismatch repair cancer syndrome 1


subject: PUBCHEM.COMPOUND:69673196

object_name: Turcot syndrome


subject: PUBCHEM.COMPOUND:69673196

object_name: Mismatch Repair Deficiency


subject: PUBCHEM.COMPOUND:69673196

object_name: pleural mesothelioma


subject: PUBCHEM.COMPOUND:69673196

object_name: malignant pleural mesothelioma


subject: PUBCHEM.COMPOUND:69673196

object_name: nonpapillary renal cell carcinoma


subject: PUBCHEM.COMPOUND:69673196

object_name: clear cell renal carcinoma


subject: PUBCHEM.COMPOUND:69673196

object_name: melanoma


subject: PUBCHEM.COMPOUND:69673196

object_name: MSI-high


subject: DRUGBANK:DB18879

subject_name: Alintegimod

object_name: Advanced cancer


subject: DRUGBANK:DB18879

object_name: Embolism, Tumor


subject: DRUGBANK:DB18879

object_name: Neoplasm Metastasis


subject: DRUGBANK:DB18879

object_name: Metastasis


subject: DRUGBANK:DB18879

object_name: Metastatic Lesion


subject: DRUGBANK:DB18879

object_name: skin neoplasm


subject: DRUGBANK:DB18879

object_name: skin cancer


subject: DRUGBANK:DB18879

object_name: renal carcinoma


subject: DRUGBANK:DB18879

object_name: kidney neoplasm


subject: DRUGBANK:DB18879

object_name: kidney cancer


subject: DRUGBANK:DB18879

object_name: Advanced Malignant Solid Neoplasm


subject: DRUGBANK:DB18879

object_name: colorectal cancer


subject: DRUGBANK:DB18879

object_name: colorectal carcinoma


subject: DRUGBANK:DB18879

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: DRUGBANK:DB18879

object_name: renal cell adenocarcinoma


subject: DRUGBANK:DB18879

object_name: renal cell carcinoma


subject: DRUGBANK:DB18879

object_name: childhood kidney cell carcinoma


subject: DRUGBANK:DB18879

object_name: adult hepatocellular carcinoma


subject: DRUGBANK:DB18879

object_name: liver cancer


subject: DRUGBANK:DB18879

object_name: pediatric hepatocellular carcinoma


subject: DRUGBANK:DB18879

object_name: liver carcinoma


subject: DRUGBANK:DB18879

object_name: non-small cell lung carcinoma


subject: DRUGBANK:DB18879

object_name: mismatch repair cancer syndrome 1


subject: DRUGBANK:DB18879

object_name: Turcot syndrome


subject: DRUGBANK:DB18879

object_name: Mismatch Repair Deficiency


subject: DRUGBANK:DB18879

object_name: pleural mesothelioma


subject: DRUGBANK:DB18879

object_name: malignant pleural mesothelioma


subject: DRUGBANK:DB18879

object_name: nonpapillary renal cell carcinoma


subject: DRUGBANK:DB18879

object_name: clear cell renal carcinoma


subject: DRUGBANK:DB18879

object_name: melanoma


subject: DRUGBANK:DB18879

object_name: MSI-high


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Metastasis


subject: CHEBI:231679

object_name: Metastatic Lesion


subject: CHEBI:231679

object_name: childhood kidney cell carcinoma


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:1391

subject_name: Midomafetamine

object_name: Narcissism


subject: CHEBI:166520

subject_name: Tenamfetamine


subject: UMLS:C5555587

subject_name: Anti-c-Met/MMAE ADC RC108

object_name: digestive system cancer


subject: CHEBI:229236

subject_name: Fezolinetant

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:229236

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:229236

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:229236

object_name: Localized Breast Carcinoma


subject: CHEBI:229236

object_name: ductal breast carcinoma in situ


subject: UMLS:C3495458

subject_name: antibodies (medication)

object_name: adult acute myeloid leukemia


subject: UMLS:C3495458

object_name: childhood acute myeloid leukemia


subject: UMLS:C3495458

object_name: childhood acute lymphoblastic leukemia


subject: UMLS:C3495458

object_name: adult acute lymphoblastic leukemia


subject: UMLS:C3495458

object_name: Secondary Myelodysplastic Syndrome


subject: UMLS:C3495458

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UMLS:C0813154

subject_name: Antibodies, in vitro diagnostic


subject: UMLS:C0813154


subject: UMLS:C0813154


subject: UMLS:C0813154


subject: UMLS:C0813154


subject: UMLS:C0813154


subject: UMLS:C0003241

subject_name: Antibodies


subject: UMLS:C0003241


subject: UMLS:C0003241


subject: UMLS:C0003241


subject: UMLS:C0003241


subject: UMLS:C0003241


subject: CHEBI:73678

object_name: Infection


subject: CHEBI:73678

object_name: infectious disease


subject: CHEBI:73678

object_name: Adverse Event Associated with Infection


subject: CHEBI:73678

object_name: Burn injury


subject: CHEBI:28864

subject_name: Tobramycin


subject: CHEBI:28864


subject: CHEBI:28864


subject: CHEBI:28864


subject: UMLS:C0678021

subject_name: Ad5CMV-p53 gene

object_name: Childhood Breast Carcinoma


subject: UMLS:C0678021

object_name: breast carcinoma


subject: UMLS:C0678021

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL2108494

subject_name: INTERFERON

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C3652465

subject_name: Interferon


subject: UMLS:C0021747

subject_name: Interferons


subject: UMLS:C0733470

subject_name: human leukocyte interferon


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b


subject: UMLS:C0021734

subject_name: Roferon-A


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a


subject: UMLS:C5666907

subject_name: Anti-TIGIT Bispecific Antibody AGEN1777

object_name: non-small cell lung carcinoma


subject: UMLS:C1707048

subject_name: broccoli sprout extract

object_name: prostate carcinoma


subject: UMLS:C1707048

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Refractory Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Refractory Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108334

subject_name: Coagulation factor VIIa Recombinant Human

object_name: factor VII deficiency


subject: CHEMBL.COMPOUND:CHEMBL2108334

object_name: congenital factor VII deficiency


subject: UMLS:C0593103

subject_name: Novoseven


subject: UMLS:C0593103


subject: PR:000007301

subject_name: coagulation factor VII


subject: PR:000007301


subject: UMLS:C4045974

subject_name: Biosimilars


subject: UMLS:C4045974


subject: GTOPDB:9517

subject_name: atacicept

object_name: EXCESS LMW-DNA


subject: CHEMBL.COMPOUND:CHEMBL1742986

subject_name: ATACICEPT


subject: UMLS:C2351058

subject_name: Atacicept


subject: CHEBI:28918

subject_name: Epinephrine

object_name: intraoperative floppy iris syndrome


subject: CHEBI:28918

object_name: Adverse reaction to adrenergic receptor antagonist


subject: CHEBI:28918

object_name: senile cataract


subject: UMLS:C5960057

subject_name: Eloralintide

object_name: Overweight


subject: UMLS:C5960057

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C5960057

object_name: obesity


subject: UMLS:C5960057

object_name: Obesity, CTCAE


subject: UMLS:C5960057

object_name: type 2 diabetes mellitus


subject: UNII:YWF427CA5D

subject_name: MACUPATIDE


subject: UNII:YWF427CA5D


subject: UNII:YWF427CA5D


subject: UNII:YWF427CA5D


subject: UNII:YWF427CA5D


subject: UNII:4RST0F28MR

subject_name: Famitinib malate

object_name: breast neoplasm


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: large cell neuroendocrine carcinoma


subject: CHEBI:41879

object_name: medullary thyroid gland carcinoma


subject: PUBCHEM.COMPOUND:131954443

subject_name: Rovalpituzumab Tesirine


subject: PUBCHEM.COMPOUND:131954443


subject: PUBCHEM.COMPOUND:131954443

object_name: melanoma


subject: PUBCHEM.COMPOUND:131954443

object_name: glioblastoma


subject: PUBCHEM.COMPOUND:131954443

object_name: Childhood Glioblastoma


subject: PUBCHEM.COMPOUND:131954443

object_name: adult glioblastoma


subject: UNII:P256HB60FF


subject: UNII:P256HB60FF


subject: UNII:P256HB60FF


subject: UNII:P256HB60FF


subject: UNII:P256HB60FF


subject: UNII:P256HB60FF


subject: UMLS:C3827079


subject: UMLS:C3827079


subject: UMLS:C3827079


subject: UMLS:C3827079


subject: UMLS:C3827079


subject: UMLS:C3827079


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: Fusion of spine, lumbar region


subject: UMLS:C5222496

subject_name: Repository Corticotropin Injection

object_name: ocular sarcoidosis


subject: UMLS:C5222496

object_name: anterior uveitis


subject: UMLS:C5222496

object_name: panuveitis


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: Compulsion


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: UMLS:C5387936

subject_name: intravenous unfractionated heparin

object_name: Traumatic amputation of hand


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: inflammatory bowel disease 1


subject: UNII:M89N0Q7EQR

object_name: Crohn disease


subject: UMLS:C3641624

subject_name: XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410

object_name: Childhood Breast Carcinoma


subject: UMLS:C3641624

object_name: breast carcinoma


subject: UMLS:C3641624

object_name: breast cancer


subject: UMLS:C4721945

subject_name: perflutren, human albumin microspheres

object_name: prostate carcinoma


subject: UNII:5Y9QQM372Q

subject_name: MENOTROPINS

object_name: infertility


subject: UNII:G1G66XE93W

object_name: Metastatic non-small cell lung cancer


subject: UNII:G1G66XE93W

object_name: squamous cell lung carcinoma


subject: UNII:G1G66XE93W

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:74705

subject_name: Met-Leu

object_name: arteriosclerosis disorder


subject: CHEBI:74705

object_name: atherosclerosis


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: UMLS:C1521807

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:6067

object_name: Stage III renal cell cancer


subject: CHEBI:6067

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:6067

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:6067

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:6067

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:6067

object_name: Renal cell carcinoma recurrent


subject: CHEBI:6067

object_name: Renal cancer recurrent


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: demyelinating disease


subject: UMLS:C0085297

object_name: Paraproteinemia


subject: CHEBI:76842

object_name: Neonatal infection


subject: CHEBI:28001

subject_name: Vancomycin


subject: UMLS:C2830141

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: Malignant Solid Neoplasm


subject: CHEBI:93786


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Crohn disease


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Esophageal Squamous Cell Carcinoma by AJCC v8 Stage


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UMLS:C5554872

subject_name: Anti-PLVAP CSR02-Fab-Tissue Factor

object_name: liver carcinoma


subject: UMLS:C5206405

subject_name: Microbial Ecosystem Therapeutics-4

object_name: head and neck squamous cell carcinoma


subject: CHEBI:145994

subject_name: Remdesivir

object_name: Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: Adult Liver Carcinoma


subject: UMLS:C4723424

subject_name: Plenvu

object_name: inflammatory bowel disease


subject: UMLS:C4723424

object_name: irritable bowel syndrome


subject: MESH:C513941

subject_name: tongxinluo

object_name: coronary artery disorder


subject: MESH:C513941

object_name: coronary atherosclerosis


subject: UMLS:C1741403

subject_name: injection, busulfan, 1 mg administered

object_name: acute leukemia


subject: UMLS:C1741403

object_name: myeloproliferative neoplasm


subject: UMLS:C1741403

object_name: Malignant myeloproliferative neoplasm


subject: UMLS:C5203416

subject_name: Busulfan Liquid Injection


subject: UMLS:C5203416


subject: UMLS:C5203416


subject: UMLS:C5907966

subject_name: HIF-2alpha Inhibitor HS-10516

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5907966

object_name: clear cell renal carcinoma


subject: UMLS:C5907966

object_name: renal cell adenocarcinoma


subject: UMLS:C5907966

object_name: renal cell carcinoma


subject: CHEBI:50733

subject_name: nutraceutical

object_name: hyperglycemia


subject: CHEBI:50733

object_name: Hyperglycemia, CTCAE


subject: CHEBI:50733

object_name: Glucose in blood specimen above reference range


subject: CHEBI:50733

object_name: Ketosis


subject: CHEBI:50733

object_name: Ketoacidosis


subject: UMLS:C5238481

subject_name: HPV E6/E7-encoding Arenavirus Vaccine HB-201

object_name: Neck Carcinoma


subject: UMLS:C5238481

object_name: head and neck neoplasm


subject: UMLS:C5238481

object_name: head and neck cancer


subject: UMLS:C5238481

object_name: HPV positive oropharyngeal squamous cell carcinoma


subject: UMLS:C5238481

object_name: human papilloma virus infection


subject: UMLS:C5238481

object_name: Human Papilloma Virus, Female


subject: UMLS:C5238481

object_name: Human Papilloma Virus, Male


subject: UNII:4B96SSC9KJ


subject: UNII:4B96SSC9KJ


subject: UNII:4B96SSC9KJ


subject: UNII:4B96SSC9KJ


subject: UNII:4B96SSC9KJ


subject: UNII:4B96SSC9KJ


subject: UNII:4B96SSC9KJ


subject: UNII:O4E1IFK37Y


subject: UNII:O4E1IFK37Y


subject: UNII:O4E1IFK37Y


subject: UNII:O4E1IFK37Y


subject: UNII:O4E1IFK37Y


subject: UNII:O4E1IFK37Y


subject: UNII:O4E1IFK37Y


subject: UMLS:C5417958

subject_name: HPV 16 E6/E7-encoding Arenavirus Vaccine HB-202


subject: UMLS:C5417958


subject: UMLS:C5417958


subject: UMLS:C5417958


subject: UMLS:C5417958


subject: UMLS:C5417958


subject: UMLS:C5417958


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UMLS:C1831593

subject_name: Denenicokin

object_name: skin melanoma


subject: UMLS:C1579314

subject_name: Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed

object_name: Fever


subject: UMLS:C1579314

object_name: Fever symptoms (finding)


subject: UMLS:C1579314

object_name: Fever, CTCAE


subject: UMLS:C1579314

object_name: Febrile Seizure


subject: UMLS:C1579314

object_name: Post vaccination fever


subject: UMLS:C3526553

subject_name: diphtheria, tetanus toxoids and acellular pertussis vaccine


subject: UMLS:C3526553


subject: UMLS:C3526553


subject: UMLS:C3526553


subject: UMLS:C3526553


subject: PUBCHEM.COMPOUND:155569720

subject_name: CARDIOPET

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:155569720

object_name: coronary atherosclerosis


subject: DRUGBANK:DB18913

subject_name: Cardiopet


subject: DRUGBANK:DB18913


subject: CHEBI:18258

subject_name: Liothyronine

object_name: thyroid disease


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: keloid


subject: UMLS:C3658854


subject: CHEBI:7496

subject_name: Nelfinavir

object_name: cytomegalovirus retinitis


subject: GTOPDB:8965

subject_name: fasinumab

object_name: osteoarthritis


subject: GTOPDB:8965

object_name: Chronic low back pain


subject: CHEMBL.COMPOUND:CHEMBL2109528

subject_name: FASINUMAB


subject: CHEMBL.COMPOUND:CHEMBL2109528


subject: UMLS:C4519593


subject: UMLS:C4519593


subject: UMLS:C1618891

subject_name: Injection, azacitidine, 1 mg administered

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C1618891

object_name: small intestine cancer


subject: UMLS:C1618891

object_name: small intestine carcinoma


subject: UMLS:C1618891

object_name: adult lymphoma


subject: UMLS:C1618891

object_name: lymphoma


subject: UMLS:C1618891

object_name: pediatric lymphoma


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:41500

subject_name: Phenylbutyrates


subject: CHEBI:41500


subject: CHEBI:41500


subject: CHEBI:41500


subject: CHEBI:41500


subject: CHEBI:41500


subject: CHEBI:44445

subject_name: Nimesulide

object_name: Childhood Breast Carcinoma


subject: CHEBI:44445

object_name: breast carcinoma


subject: CHEBI:44445

object_name: breast cancer


subject: DRUGBANK:DB16615

subject_name: Krill oil

object_name: type 2 diabetes mellitus


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: cervical intraepithelial neoplasia


subject: UNII:DPT0O3T46P

object_name: dysplasia of cervix


subject: UNII:DPT0O3T46P

object_name: Cervical intraepithelial neoplasia grade 2


subject: UNII:DPT0O3T46P

object_name: Cervical Squamous Cell Carcinoma In Situ


subject: CHEBI:132922

object_name: Uses contraception (finding)


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Non-small cell lung cancer stage IIIA


subject: UMLS:C4541385

subject_name: Heplisav-B

object_name: hepatitis A


subject: UMLS:C4541385

object_name: hepatitis


subject: CHEBI:58097

object_name: Pharyngeal dysfunction


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:8802

subject_name: Remifentanil


subject: GTOPDB:1160

subject_name: hCG

object_name: Supervision of pregnancy resulting from in-vitro fertilization


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: PUBCHEM.COMPOUND:17753757

subject_name: Pimecrolimus

object_name: seborrheic dermatitis


subject: CHEBI:231673

subject_name: Hyaluronidase

object_name: Post-Operative Pain


subject: PUBCHEM.COMPOUND:91820602


subject: UMLS:C5417847

subject_name: Aryl Hydrocarbon Receptor Inhibitor IK-175

object_name: Cancer of Neck


subject: UMLS:C5417847

object_name: Neck Carcinoma


subject: UMLS:C5417847

object_name: head and neck neoplasm


subject: UMLS:C5417847

object_name: head and neck cancer


subject: UMLS:C5417847

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5417847

object_name: Cancer of Head


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: anemia


subject: PUBCHEM.COMPOUND:172866837

subject_name: Enlicitide Decanoate

object_name: arteriosclerosis disorder


subject: UNII:PSR59MCX5M

subject_name: ENLICITIDE DECANOATE


subject: UMLS:C4705850

object_name: breast neoplasm


subject: UMLS:C4705850


subject: CHEBI:32150

object_name: nephrolithiasis, calcium oxalate


subject: CHEBI:32150

object_name: nephrolithiasis


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: intrahepatic cholangiocarcinoma


subject: CHEBI:41879

object_name: Small Duct Intrahepatic Cholangiocarcinoma


subject: CHEBI:193615


subject: CHEBI:60761

subject_name: Floxuridine


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:45783

subject_name: Imatinib

object_name: mucosal melanoma


subject: CHEBI:6121

subject_name: Ketamine

object_name: Uterine cramps


subject: CHEBI:32599


subject: UNII:K5E0V85NB9

subject_name: Carrimycin


subject: UNII:K5E0V85NB9

object_name: oral cavity squamous cell carcinoma


subject: UNII:2GFP9BJD79

subject_name: Glucarpidase

object_name: neoplasm


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide

object_name: Alzheimer disease 3


subject: UMLS:C3827119

subject_name: Recombinant Human Adenovirus Type 5 H101

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:85994

subject_name: Lenvatinib


subject: UMLS:C5855180

subject_name: Anti-CD19 Antibody-drug Conjugate

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5855180

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UMLS:C5855180

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C4086532

object_name: aggressive systemic mastocytosis


subject: DRUGBANK:DB13195

subject_name: Horse chestnut

object_name: lymphedema of arm


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:52717

object_name: myelofibrosis


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:D7RD81HE4W

object_name: mantle cell lymphoma


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W

object_name: myeloproliferative neoplasm


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W

object_name: marginal zone lymphoma


subject: UNII:D7RD81HE4W

object_name: MALT lymphoma


subject: UNII:D7RD81HE4W

object_name: follicular lymphoma


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: CHEBI:2668

subject_name: Amlodipine

object_name: Graft failure


subject: UNII:FIK1414ZI8

subject_name: Odiparcil

object_name: atrial fibrillation


subject: UNII:FIK1414ZI8

object_name: Atrial Fibrillation by ECG Finding


subject: UNII:FIK1414ZI8

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:94809

subject_name: Itopride

object_name: Primary bacterial peritonitis


subject: CHEBI:94809

object_name: acute spontaneous bacterial peritonitis


subject: CHEBI:2639

subject_name: Amiloride

object_name: optic neuritis


subject: CHEBI:2639

object_name: multiple sclerosis


subject: UMLS:C5959222

subject_name: Anti-HLA-G/CD3 Bispecific Antibody RO7515629

object_name: pancreatic adenocarcinoma


subject: UMLS:C5959222

object_name: non-small cell lung carcinoma


subject: UMLS:C5959222

object_name: colorectal cancer


subject: UMLS:C5959222

object_name: colorectal carcinoma


subject: UMLS:C5959222

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5959222

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5959222

object_name: clear cell renal carcinoma


subject: UMLS:C5959222

object_name: renal cell adenocarcinoma


subject: UMLS:C5959222

object_name: renal cell carcinoma


subject: UMLS:C5959222

object_name: ovarian cancer


subject: UMLS:C5959222

object_name: ovarian neoplasm


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: UMLS:C2347428

subject_name: PNP-Expressing Ovine Atadenovirus FP253

object_name: prostate carcinoma


subject: UMLS:C2347428

object_name: prostate cancer


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Knee Injuries


subject: CHEBI:5855

subject_name: Ibuprofen


subject: RXCUI:857002

subject_name: acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet

object_name: opioid use


subject: RXCUI:857002


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: osteoarthritis, knee


subject: UMLS:C4527194

subject_name: Protease Inhibitor Formulation LB1148

object_name: septic shock


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Ascites


subject: CHEBI:38940

object_name: Ascites, CTCAE


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: delirium


subject: PUBCHEM.COMPOUND:74030550

object_name: Delirium, CTCAE


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: euthyroid sick syndrome


subject: CHEBI:28939

object_name: acute myocardial infarction


subject: CHEBI:28939

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:28939

object_name: myocardial ischemia


subject: CHEBI:28939

object_name: Family history of ischemic heart disease


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: paralytic ileus


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:U59UGK3IPC

subject_name: Ublituximab

object_name: diffuse large B-cell lymphoma


subject: UNII:U59UGK3IPC

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:U59UGK3IPC

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UNII:38073MQB2A

subject_name: Umbralisib


subject: UNII:38073MQB2A


subject: UNII:38073MQB2A


subject: CHEBI:49325

subject_name: oral contraceptive

object_name: neoplasm


subject: UMLS:C0009905

subject_name: Contraceptives, Oral


subject: MESH:C000654530

object_name: long COVID-19


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: malignant testicular germ cell tumor


subject: CHEBI:63584

object_name: neoplasm of testis


subject: CHEBI:63584

object_name: testicular cancer


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: Cognitive changes


subject: PUBCHEM.COMPOUND:54675783

object_name: mood (physical finding)


subject: UMLS:C4721945

subject_name: perflutren, human albumin microspheres

object_name: Adnexal mass


subject: PUBCHEM.COMPOUND:1549163

subject_name: Silybin

object_name: Advanced Hepatocellular Carcinoma


subject: CHEBI:9144

subject_name: Silibinin


subject: CHEBI:172705

subject_name: DEHYDROSILYLBIN


subject: CHEBI:125451

subject_name: silymarin


subject: UMLS:C5691215

object_name: Coronavinae infectious disease


subject: UMLS:C0163401

subject_name: aryldialkylphosphatase

object_name: carotid stenosis


subject: UMLS:C0052451

subject_name: Arylesterase


subject: MESH:C000710250

object_name: digestive system disorder


subject: MESH:C000710250

object_name: colonic disease


subject: MESH:C000710250

object_name: gastrointestinal disease


subject: MESH:C000710250

object_name: intestinal disorder


subject: PUBCHEM.COMPOUND:92002593

subject_name: Ibritumomab

object_name: mantle cell lymphoma


subject: PUBCHEM.COMPOUND:92002593

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:92002593

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:4Q52C550XK

subject_name: Ibritumomab tiuxetan


subject: UNII:4Q52C550XK


subject: UNII:4Q52C550XK


subject: CHEBI:151315

subject_name: Heparin

object_name: placental insufficiency


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: PR:000014986

subject_name: solute carrier family 22 member 18

object_name: Post-Operative Pain


subject: CHEBI:149520

subject_name: Polihexanide

object_name: chronic ulcer of skin


subject: CHEBI:84739


subject: CHEBI:2637

subject_name: Amikacin


subject: PUBCHEM.COMPOUND:16170201

subject_name: TEICOPLANIN


subject: PR:000015526

subject_name: transcription factor Spi-C


subject: UMLS:C0033374

subject_name: Prolactin-Releasing Hormone


subject: UMLS:C0445115

subject_name: Normal saline


subject: CHEBI:67272

subject_name: Perifosine

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: cardiovascular disorder


subject: UMLS:C5204506

subject_name: Pavunalimab

object_name: metastatic melanoma


subject: UMLS:C5204506

object_name: Advanced Melanoma


subject: UMLS:C4763714

subject_name: Izuralimab


subject: UMLS:C4763714


subject: CHEBI:9605

subject_name: Tirofiban

object_name: ST Elevation Myocardial Infarction


subject: UMLS:C4537797

subject_name: Tdap vaccine administration

object_name: preeclampsia


subject: UMLS:C4537797

object_name: Adverse reaction to diphtheria, pertussis, and tetanus vaccine


subject: UNII:2CN60TN6ZS

subject_name: Lurbinectedin

object_name: Hepatic impairment


subject: CHEBI:47808

subject_name: Sulforaphane

object_name: Prostate cancer recurrent


subject: CHEBI:47808

object_name: prostate adenocarcinoma


subject: UMLS:C2350806

subject_name: TSE 424

object_name: osteoporosis


subject: UMLS:C2350806

object_name: Encounter due to family history of osteoporosis


subject: UMLS:C2350806

object_name: Osteoporosis, CTCAE 5.0


subject: UMLS:C2350806

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: Diabetic foot ulcer


subject: UMLS:C3714803

object_name: Diabetic wound


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:41948

subject_name: Eflornithine

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:41948

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:41948

object_name: anaplastic astrocytoma


subject: CHEBI:41948

object_name: Recurrent Anaplastic Astrocytoma


subject: CHEBI:41948

object_name: Recurrent Childhood Anaplastic Astrocytoma


subject: CHEBI:6520

subject_name: Lomustine


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Immunocompromised Host


subject: CHEBI:6888

object_name: Adverse effects in the therapeutic use of immunosuppressive agents


subject: UMLS:C0445115

object_name: Erythema


subject: CHEBI:37670

subject_name: protease inhibitor

object_name: HIV infection


subject: CHEBI:37670

object_name: AIDS


subject: UMLS:C0033607

subject_name: Protease Inhibitors


subject: UMLS:C0033607


subject: UMLS:C1268897

subject_name: Retroviral protease inhibitor


subject: UMLS:C1268897


subject: UMLS:C3536890

subject_name: Protease Inhibitor [EPC]


subject: UMLS:C3536890


subject: CHEBI:8768

subject_name: Rabeprazole

object_name: sign or symptom


subject: CHEBI:75179

subject_name: Trifluridine

object_name: Recurrent Rectal Cancer


subject: CHEBI:75179

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:75179

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:75179

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Advanced Hepatocellular Carcinoma


subject: UMLS:C2346820


subject: UNII:8Y3GDT6YWV

object_name: secretory diarrhea


subject: UMLS:C3658787


subject: CHEBI:32295

subject_name: vindesine sulfate

object_name: Mature B-Cell Non-Hodgkin Lymphoma


subject: CHEBI:36373

subject_name: vindesine


subject: UNII:7V6HE3DM5A

subject_name: Ocriplasmin

object_name: wet macular degeneration


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: esophageal atresia


subject: UMLS:C4330852

subject_name: Oligomeric Procyanidin Complex

object_name: prostate carcinoma


subject: UMLS:C4330852

object_name: prostate cancer


subject: UMLS:C4756641

subject_name: Hydroxychloroquine only product in oral dose form

object_name: Coronavinae infectious disease


subject: PUBCHEM.COMPOUND:74328238

subject_name: Sotagliflozin

object_name: Stage 3 chronic kidney disease


subject: PUBCHEM.COMPOUND:78140854

subject_name: Ivosidenib

object_name: Cholangiocarcinoma non-resectable


subject: PUBCHEM.COMPOUND:78140854

object_name: Metastatic cholangiocarcinoma


subject: PUBCHEM.COMPOUND:71717200

subject_name: Istaroxime

object_name: cardiogenic shock


subject: UMLS:C2984212

subject_name: Deuterated 3-Methylhistidine

object_name: Cachexia


subject: UMLS:C1327783

object_name: Oral Mucositis


subject: UMLS:C1327783

object_name: stomatitis


subject: UMLS:C1327783

object_name: oral mucositis


subject: UMLS:C1327783

object_name: Neck Carcinoma


subject: UMLS:C1327783

object_name: head and neck neoplasm


subject: UMLS:C1327783

object_name: head and neck cancer


subject: UMLS:C1327783

object_name: mouth disorder


subject: UMLS:C1327783

object_name: Oral ulcer


subject: CHEBI:30006

subject_name: L-leucine residue

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:30006

object_name: obesity


subject: CHEBI:30006

object_name: Obesity, CTCAE


subject: CHEBI:30006

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:30006

object_name: metabolic syndrome X


subject: CHEBI:32682

subject_name: L-argininium


subject: CHEBI:32682


subject: CHEBI:32682


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:29952


subject: CHEBI:29952


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:25017

subject_name: leucine


subject: CHEBI:25017


subject: CHEBI:25017


subject: CHEBI:25017


subject: CHEBI:25017


subject: CHEBI:181423

subject_name: CALCIFEDIOL

object_name: Fat malabsorption


subject: CHEBI:181423

object_name: vitamin D deficiency


subject: UMLS:C3714609

subject_name: Calcifediol Drug Class


subject: UMLS:C3714609


subject: CHEBI:17933

subject_name: Calcifediol


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C5907908

subject_name: ALK Inhibitor SY-3505

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:4I7U5C459M

object_name: multiple sclerosis


subject: CHEBI:47519

subject_name: Ketoconazole


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: Physical stress


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Stage IV Prostate Cancer AJCC v7


subject: PR:000005931


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: nephrolithiasis


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: PUBCHEM.COMPOUND:18463831

subject_name: Cyclophosphamide Cyclophosphamide

object_name: leukemia


subject: PUBCHEM.COMPOUND:18463831

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:18463831

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:18463831

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:18463831

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:18463831

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:18463831

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: PUBCHEM.COMPOUND:18463831

object_name: aplastic anemia


subject: PUBCHEM.COMPOUND:18463831

object_name: idiopathic aplastic anemia


subject: PUBCHEM.COMPOUND:9554281

subject_name: (-)-Cyclophosphamide


subject: PUBCHEM.COMPOUND:9554281


subject: PUBCHEM.COMPOUND:9554281


subject: PUBCHEM.COMPOUND:9554281


subject: PUBCHEM.COMPOUND:9554281


subject: PUBCHEM.COMPOUND:9554281


subject: PUBCHEM.COMPOUND:9554281


subject: PUBCHEM.COMPOUND:9554281


subject: PUBCHEM.COMPOUND:9554281


subject: UNII:26496N541O

subject_name: Cyclosporin E


subject: UNII:26496N541O


subject: UNII:26496N541O


subject: UNII:26496N541O


subject: UNII:26496N541O


subject: UNII:26496N541O


subject: UNII:26496N541O


subject: UNII:26496N541O


subject: UNII:26496N541O


subject: UNII:951G84HQ4I

object_name: ocular hypertension


subject: UNII:951G84HQ4I

object_name: Ocular hypertension


subject: UMLS:C3639986

subject_name: Fluenz

object_name: influenza


subject: UNII:8MSY49469G

subject_name: Fluoromisonidazole F-18

object_name: prostate adenocarcinoma


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: food allergy


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C2830067

object_name: Metastatic malignant neoplasm to pancreas


subject: PUBCHEM.COMPOUND:11670360

subject_name: Nirogacestat


subject: UMLS:C0021027

subject_name: Immunoglobulins

object_name: hemolytic anemia


subject: UMLS:C0021027

object_name: non-autoimmune hemolytic anemia


subject: UMLS:C0021027

object_name: multifocal motor neuropathy


subject: CHEBI:66903

subject_name: Vismodegib

object_name: Primary malignant neoplasm


subject: CHEBI:66903

object_name: childhood malignant neoplasm


subject: CHEBI:66903

object_name: Malignant obstetric neoplasm


subject: UMLS:C4305779

object_name: irritable bowel syndrome


subject: CHEBI:5959

subject_name: Irbesartan

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: endometriosis


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: mast cell leukemia


subject: PUBCHEM.COMPOUND:71226663

object_name: Multiple cutaneous leiomyomas


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C3273932

subject_name: Carbon C 13 Sodium Octanoate

object_name: liver carcinoma


subject: UMLS:C3273932

object_name: Chronic liver disease


subject: UMLS:C4331950

object_name: breast neoplasm


subject: UMLS:C4085985

subject_name: sabatolimab

object_name: glioblastoma


subject: UMLS:C4085985

object_name: Brain Stem Glioblastoma


subject: UMLS:C4085985

object_name: glioma susceptibility 1


subject: CHEBI:90227

subject_name: Selumetinib

object_name: acute lymphoblastic leukemia


subject: CHEBI:90227

object_name: adult acute lymphoblastic leukemia


subject: CHEBI:90227

object_name: Acute lymphoblastic leukemia, in relapse


subject: CHEBI:90227

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:90227

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:3219

subject_name: Bupropion

object_name: methamphetamine dependence


subject: MESH:C487773

subject_name: trans-sodium crocetinate


subject: MESH:C487773

object_name: Childhood Glioblastoma


subject: MESH:C487773

object_name: adult glioblastoma


subject: MESH:C487773

object_name: glioma


subject: CHEBI:63639

subject_name: tetrasulfocyanine


subject: CHEBI:63639


subject: CHEBI:63639


subject: CHEBI:63639


subject: CHEBI:16031

subject_name: Indoleacetamide


subject: CHEBI:16031


subject: CHEBI:16031


subject: CHEBI:16031


subject: PR:000016240

subject_name: calcineurin B homologous protein 3


subject: PR:000016240


subject: PR:000016240


subject: PR:000016240


subject: PR:000016708

subject_name: hamartin


subject: PR:000016708


subject: PR:000016708


subject: PR:000016708


subject: PR:000014926

subject_name: solute carrier family 12 member 3


subject: PR:000014926


subject: PR:000014926


subject: PR:000014926


subject: PR:000022673

subject_name: antigen 43

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:71957


subject: UNII:60ES45KTMK

subject_name: Pilaralisib

object_name: Childhood Breast Carcinoma


subject: UNII:60ES45KTMK

object_name: breast carcinoma


subject: UNII:60ES45KTMK

object_name: breast cancer


subject: UNII:60ES45KTMK

object_name: breast neoplasm


subject: UMLS:C3657458


subject: UMLS:C3657458


subject: UMLS:C3657458


subject: UMLS:C3657458


subject: UMLS:C0388976

subject_name: Ecteinascidin 743

object_name: prostate carcinoma


subject: UMLS:C0388976

object_name: prostate cancer


subject: CHEBI:61048

subject_name: Ganglioside GM1

object_name: plasma cell myeloma


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: Surgical procedure finding


subject: UMLS:C5669600

subject_name: Ivonescimab

object_name: cancer


subject: UMLS:C5669600

object_name: nervous system cancer


subject: CHEBI:4356

subject_name: Deferoxamine

object_name: brain ischemia


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA

object_name: PSA Failure


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Effects of chemotherapy


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C5432400

subject_name: Hunterase

object_name: Hunter Syndrome


subject: DRUGBANK:DB01404

subject_name: Ginseng

object_name: Malignant neoplasm of female breast


subject: DRUGBANK:DB14296

subject_name: Panax quinquefolius whole


subject: CHEBI:76004

subject_name: Dimethyl fumarate

object_name: secondary progressive multiple sclerosis


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Recurrent Childhood Glioblastoma


subject: UNII:KXG2PJ551I

object_name: Recurrent Glioblastoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3274703


subject: UMLS:C3274703


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:16480

object_name: pulmonary arterial hypertension


subject: UMLS:C4044446

object_name: ulcerative colitis


subject: UMLS:C4044446

object_name: inflammatory bowel disease 1


subject: UNII:XX2MN88N5D

subject_name: Efalizumab

object_name: Macular Edema


subject: UNII:XX2MN88N5D

object_name: uveitis


subject: UNII:XX2MN88N5D

object_name: Uveitis, CTCAE


subject: UMLS:C5417882

subject_name: Anti-PD-1/Anti-PD-L1 Bispecific Antibody IBI318

object_name: small cell lung carcinoma


subject: CHEBI:3084

subject_name: Bethanechol

object_name: Dysfunction of urinary bladder


subject: CHEBI:49603

subject_name: Lapatinib

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:49603

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:41774

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:41774

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:29007

object_name: amyotrophic lateral sclerosis


subject: CHEBI:73272

subject_name: CANAGLIFLOZIN

object_name: Prediabetes


subject: CHEBI:73272

object_name: HIV infection


subject: PUBCHEM.COMPOUND:74323022

subject_name: Canagliflozin


subject: PUBCHEM.COMPOUND:74323022


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: head and neck squamous cell carcinoma


subject: CHEBI:173554

subject_name: Ethyl 3-mercaptopropanoic acid

object_name: cocaine abuse


subject: CHEBI:9586

subject_name: Tiagabine


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: monocytic leukemia


subject: CHEBI:4026

object_name: acute monocytic leukemia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: myeloid leukemia


subject: UNII:4Z63YK6E0E


subject: UNII:4Z63YK6E0E


subject: UMLS:C1699394

subject_name: Hylenex


subject: UMLS:C1699394

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C1699394

object_name: acute myeloid leukemia


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Recurrent lung cancer


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Recurrent Endometrial Cancer


subject: CHEBI:4672


subject: CHEBI:4672

object_name: Non-small cell carcinoma


subject: CHEBI:231679

subject_name: ipilimumab

object_name: endometrial cancer


subject: CHEBI:231679

object_name: uterine corpus cancer


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:63724


subject: CHEBI:63724


subject: UMLS:C4330586

subject_name: LXR-b Agonist RGX-104


subject: UMLS:C4330586


subject: UMLS:C4330586

object_name: endometrial carcinoma


subject: UMLS:C4330586


subject: UMLS:C4330586

object_name: lung cancer


subject: UMLS:C4330586

object_name: lung neoplasm


subject: UMLS:C4330586

object_name: lung carcinoma


subject: UMLS:C4330586


subject: UMLS:C4330586

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C4330586


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: oropharynx squamous cell carcinoma


subject: UMLS:C4053601


subject: UNII:D68OW5RS98

subject_name: VIDUTOLIMOD

object_name: non-small cell lung carcinoma


subject: UNII:D68OW5RS98

object_name: triple-negative breast carcinoma


subject: UNII:D68OW5RS98

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:D68OW5RS98

object_name: skin squamous cell carcinoma


subject: UNII:D68OW5RS98

object_name: cutaneous squamous cell carcinoma


subject: UNII:D68OW5RS98


subject: UNII:D68OW5RS98

object_name: trabecular adenocarcinoma


subject: UNII:D68OW5RS98

object_name: cutaneous neuroendocrine carcinoma


subject: UNII:D68OW5RS98

object_name: basal cell carcinoma


subject: UNII:D68OW5RS98

object_name: skin basal cell carcinoma


subject: GTOPDB:13624

subject_name: inclisiran

object_name: kidney failure


subject: UMLS:C5854571

subject_name: Anti-BTLA Monoclonal Antibody HFB200603

object_name: Stomach cancer


subject: UMLS:C5854571

object_name: gastric cancer


subject: UMLS:C5854571

object_name: colorectal cancer


subject: UMLS:C5854571

object_name: colorectal carcinoma


subject: UMLS:C5854571

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5854571


subject: UMLS:C5854571

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5854571

object_name: clear cell renal carcinoma


subject: UMLS:C5854571

object_name: renal cell adenocarcinoma


subject: UMLS:C5854571

object_name: renal cell carcinoma


subject: UMLS:C5854571

object_name: melanoma


subject: CHEBI:5123

subject_name: Fluphenazine

object_name: psoriasis


subject: CHEBI:5778

subject_name: Hydrochlorothiazide

object_name: Hypernatremia


subject: CHEBI:5778

object_name: Hypernatremia, CTCAE


subject: CHEBI:5778

object_name: Critical Illness


subject: CHEMBL.COMPOUND:CHEMBL1743018

subject_name: FICLATUZUMAB

object_name: acute myeloid leukemia by FAB classification


subject: CHEMBL.COMPOUND:CHEMBL1743018

object_name: acute myeloid leukemia


subject: UMLS:C2703138

subject_name: ficlatuzumab


subject: UMLS:C2703138


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: Brainstem death


subject: UMLS:C1881373

object_name: Brain Death


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: BRAF V600K Mutation Present


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:84040

object_name: Menopause present (finding)


subject: CHEBI:84040

object_name: Menopause


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:36002


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:27881


subject: UMLS:C1446647

subject_name: Milk antigen

object_name: Overweight


subject: UMLS:C1446647

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C1446647

object_name: obesity


subject: UMLS:C1446647

object_name: Obesity, CTCAE


subject: DRUGBANK:DB10543

subject_name: Cow milk


subject: UMLS:C0444318

subject_name: Milk Specimen


subject: UMLS:C0444318


subject: UMLS:C0444318


subject: UMLS:C0444318


subject: CHEBI:4445

subject_name: Desflurane

object_name: colorectal neoplasm


subject: GTOPDB:9802

object_name: Acne inversa


subject: UMLS:C4548814


subject: UNII:59CF90960T


subject: DRUGBANK:DB16452


subject: UMLS:C3896750


subject: UMLS:C3896811

subject_name: Anti-gpA33/CD3 Monoclonal Antibody MGD007

object_name: colorectal carcinoma


subject: CHEBI:6801

subject_name: Metformin

object_name: Drug Interactions


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: degenerative myopia


subject: CHEBI:138016

subject_name: MPA

object_name: Shoulder pain


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:6715

subject_name: medroxyprogesterone


subject: PR:000012478

subject_name: rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha


subject: UniProtKB:P27664

subject_name: PDE6A_MOUSE Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha (sprot)


subject: UMLS:C1831903

object_name: Childhood Breast Carcinoma


subject: UMLS:C1831903

object_name: breast carcinoma


subject: UMLS:C1831903

object_name: breast cancer


subject: CHEBI:1989

subject_name: Modufolin


subject: UMLS:C4760869


subject: CHEBI:9637

subject_name: Torasemide

object_name: chronic kidney disease


subject: CHEBI:9637

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:28358

subject_name: rac-lactic acid

object_name: lumbar disc herniation


subject: CHEBI:42111

subject_name: D-Lactic acid


subject: CHEBI:16411

subject_name: Indoleacetic acid


subject: CHEBI:78320

subject_name: Lactic acid


subject: UMLS:C5557619

subject_name: Anti-CD47/Anti-PD-L1 Bispecific Antibody PF-07257876

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5557619

object_name: non-small cell lung carcinoma


subject: UMLS:C5557619

object_name: ovarian cancer


subject: UMLS:C5557619

object_name: ovarian neoplasm


subject: UMLS:C5557619

object_name: ovarian carcinoma


subject: UMLS:C0282248

subject_name: Novantrone

object_name: prostate carcinoma


subject: UMLS:C0282248

object_name: prostate cancer


subject: DRUGBANK:DB15803

subject_name: Dendritic cells vaccine

object_name: Refractory Leukemia


subject: DRUGBANK:DB15803

object_name: adult T-cell leukemia/lymphoma


subject: DRUGBANK:DB15803

object_name: acute myeloid leukemia


subject: DRUGBANK:DB15803

object_name: acute lymphoblastic leukemia


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: Acquired deformity of elbow


subject: CHEBI:31772


subject: UMLS:C0875986

subject_name: Chirocaine


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: UMLS:C1529682

object_name: Neuroblastoma recurrent


subject: CHEBI:231679

subject_name: ipilimumab

object_name: bladder tumor


subject: CHEBI:231679

object_name: urinary bladder carcinoma


subject: CHEBI:231679

object_name: urinary bladder cancer


subject: CHEBI:231679

object_name: childhood bladder carcinoma


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA

object_name: Neoplasm of uncertain or unknown behavior of prostate


subject: UNII:9AG41L3AOQ

object_name: grade III prostatic intraepithelial neoplasia


subject: UNII:9AG41L3AOQ

object_name: benign neoplasm of prostate


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: membranous glomerulonephritis


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: UNII:FM5526K07A

subject_name: ZINC ACETATE

object_name: heart failure


subject: UNII:FM5526K07A

object_name: Heart Failure, CTCAE


subject: UNII:FM5526K07A

object_name: cardiomyopathy


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: hereditary sensory and autonomic neuropathy type 5


subject: CHEBI:6149


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:600103

subject_name: daptomycin

object_name: Critical Illness


subject: CHEBI:33380

subject_name: thulium atom

object_name: hypertension


subject: CHEBI:33380

object_name: Hypertension, CTCAE


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:74861


subject: CHEBI:55460

subject_name: trimellityl group


subject: CHEBI:55460


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: CHEBI:30703


subject: UMLS:C3166394

subject_name: Tm antigen


subject: UMLS:C3166394


subject: PR:000002105

subject_name: thrombomodulin


subject: PR:000002105


subject: CHEBI:135779

subject_name: Amrubicin


subject: CHEBI:135779


subject: CHEBI:135779


subject: CHEBI:135779


subject: CHEBI:119915

subject_name: Fentanyl

object_name: arthritis


subject: CHEBI:119915

object_name: Arthritis, CTCAE


subject: UMLS:C0306371

subject_name: Humulin R

object_name: acute kidney failure


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: osteoarthritis, knee


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C3536840

subject_name: Nonsteroidal Anti-inflammatory Drug [EPC]


subject: UNII:082285VIDF

subject_name: fluoromisonidazole

object_name: liver cancer


subject: UNII:082285VIDF

object_name: liver neoplasm


subject: UNII:082285VIDF

object_name: Klatskin Tumor


subject: UNII:8MSY49469G

subject_name: Fluoromisonidazole F-18


subject: UNII:8MSY49469G


subject: UNII:8MSY49469G

object_name: liver carcinoma


subject: UNII:8MSY49469G


subject: DRUGBANK:DB16519

subject_name: Zofin

object_name: severe acute respiratory syndrome


subject: DRUGBANK:DB16519

object_name: acute respiratory distress syndrome


subject: DRUGBANK:DB16519

object_name: adult acute respiratory distress syndrome


subject: DRUGBANK:DB16519

object_name: Coronavinae infectious disease


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: extranodal nasal NK/T cell lymphoma


subject: UMLS:C1832035


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Metastatic Carcinoma to the Uterine Cervix


subject: UMLS:C3827082


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: oropharyngeal carcinoma


subject: CHEBI:6888

object_name: oropharynx cancer


subject: CHEBI:6888

object_name: cranial nerve neuropathy


subject: CHEBI:6888

object_name: Neck Carcinoma


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: plasma cell myeloma


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: CHEBI:7454

subject_name: Nalbuphine

object_name: childhood malignant neoplasm


subject: CHEBI:75722

subject_name: Tramadol


subject: UMLS:C4733593

subject_name: cytidine-phosphate-guanosine DNA


subject: UMLS:C5446554

object_name: skin carcinoma


subject: UMLS:C5446554

object_name: esophageal cancer


subject: UMLS:C5446554

object_name: Childhood Breast Carcinoma


subject: UMLS:C5446554

object_name: breast carcinoma


subject: UMLS:C5446554

object_name: breast cancer


subject: UMLS:C3827097

object_name: Immunoglobulin deposition disease


subject: PUBCHEM.COMPOUND:70105374

subject_name: Pitavastatin Lactone

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:32020

subject_name: Pitavastatin


subject: CHEMBL.COMPOUND:CHEMBL1200571

subject_name: GADOBENATE DIMEGLUMINE

object_name: multiple sclerosis


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: adult brainstem glioma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: adult intracranial malignant hemangiopericytoma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: Adult Grade II Meningioma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: Adult Mixed Glioma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: Adult Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: Recurrent Adult Brain Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: Adult Anaplastic Oligodendroglioma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: Adult Anaplastic (Malignant) Meningioma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: adult oligodendroglioma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: Adult Giant Cell Glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: Adult Anaplastic Astrocytoma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: Adult Pineal Gland Astrocytoma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: adult anaplastic ependymoma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: adult choroid plexus neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: adult papillary meningioma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: adult glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: Adult Gliosarcoma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: Adult Diffuse Astrocytoma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: adult embryonal tumor with multilayered rosettes, c19mc-altered


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: adult medulloblastoma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: adult pineoblastoma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: Adult Ependymoma


subject: UNII:3Q6PPC19PO

object_name: multiple sclerosis


subject: UNII:3Q6PPC19PO

object_name: adult brainstem glioma


subject: UNII:3Q6PPC19PO

object_name: adult intracranial malignant hemangiopericytoma


subject: UNII:3Q6PPC19PO

object_name: Adult Grade II Meningioma


subject: UNII:3Q6PPC19PO

object_name: Adult Mixed Glioma


subject: UNII:3Q6PPC19PO

object_name: Adult Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: UNII:3Q6PPC19PO

object_name: Recurrent Adult Brain Neoplasm


subject: UNII:3Q6PPC19PO

object_name: Adult Anaplastic Oligodendroglioma


subject: UNII:3Q6PPC19PO

object_name: Adult Anaplastic (Malignant) Meningioma


subject: UNII:3Q6PPC19PO

object_name: adult oligodendroglioma


subject: UNII:3Q6PPC19PO

object_name: Adult Giant Cell Glioblastoma


subject: UNII:3Q6PPC19PO

object_name: Adult Anaplastic Astrocytoma


subject: UNII:3Q6PPC19PO

object_name: Adult Pineal Gland Astrocytoma


subject: UNII:3Q6PPC19PO

object_name: adult anaplastic ependymoma


subject: UNII:3Q6PPC19PO

object_name: adult choroid plexus neoplasm


subject: UNII:3Q6PPC19PO

object_name: adult papillary meningioma


subject: UNII:3Q6PPC19PO

object_name: adult glioblastoma


subject: UNII:3Q6PPC19PO

object_name: Adult Gliosarcoma


subject: UNII:3Q6PPC19PO

object_name: Adult Diffuse Astrocytoma


subject: UNII:3Q6PPC19PO

object_name: adult embryonal tumor with multilayered rosettes, c19mc-altered


subject: UNII:3Q6PPC19PO

object_name: adult medulloblastoma


subject: UNII:3Q6PPC19PO

object_name: adult pineoblastoma


subject: UNII:3Q6PPC19PO

object_name: Adult Ependymoma


subject: CHEBI:68841

subject_name: Gadobutrol

object_name: multiple sclerosis


subject: CHEBI:68841

object_name: adult brainstem glioma


subject: CHEBI:68841

object_name: adult intracranial malignant hemangiopericytoma


subject: CHEBI:68841

object_name: Adult Grade II Meningioma


subject: CHEBI:68841

object_name: Adult Mixed Glioma


subject: CHEBI:68841

object_name: Adult Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: CHEBI:68841

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:68841

object_name: Adult Anaplastic Oligodendroglioma


subject: CHEBI:68841

object_name: Adult Anaplastic (Malignant) Meningioma


subject: CHEBI:68841

object_name: adult oligodendroglioma


subject: CHEBI:68841

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:68841

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:68841

object_name: Adult Pineal Gland Astrocytoma


subject: CHEBI:68841

object_name: adult anaplastic ependymoma


subject: CHEBI:68841

object_name: adult choroid plexus neoplasm


subject: CHEBI:68841

object_name: adult papillary meningioma


subject: CHEBI:68841

object_name: adult glioblastoma


subject: CHEBI:68841

object_name: Adult Gliosarcoma


subject: CHEBI:68841

object_name: Adult Diffuse Astrocytoma


subject: CHEBI:68841

object_name: adult embryonal tumor with multilayered rosettes, c19mc-altered


subject: CHEBI:68841

object_name: adult medulloblastoma


subject: CHEBI:68841

object_name: adult pineoblastoma


subject: CHEBI:68841

object_name: Adult Ependymoma


subject: UMLS:C1120338

subject_name: casein phosphopeptide-amorphous calcium phosphate nanocomplex

object_name: White Spot Lesion


subject: CHEBI:6541

subject_name: Losartan

object_name: preeclampsia postpartum


subject: CHEBI:71954

subject_name: Buparlisib

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:71954

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:71954

object_name: MALT lymphoma


subject: CHEBI:71954

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:71954

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:71954

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:71954

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:71954

object_name: splenic marginal zone lymphoma


subject: CHEBI:71954

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C0304229

subject_name: Experimental drug

object_name: malignant neoplasm of cervix stage IVb


subject: UMLS:C0304229

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: UMLS:C5206815


subject: UMLS:C5206815


subject: PUBCHEM.COMPOUND:78357831

subject_name: micafungin

object_name: acute leukemia


subject: UMLS:C0879264


subject: CHEBI:6030

subject_name: Isoniazid

object_name: type 1 diabetes mellitus 1


subject: CHEBI:6030

object_name: type 1 diabetes mellitus


subject: CHEBI:8499

subject_name: Propranolol

object_name: Plasma cell myeloma refractory


subject: CHEBI:8499

object_name: Plasma cell myeloma recurrent


subject: CHEBI:8499

object_name: smoldering plasma cell myeloma


subject: CHEBI:73044

subject_name: Lumiracoxib

object_name: Primary gout


subject: CHEBI:231681

subject_name: olaratumab

object_name: non-small cell lung carcinoma


subject: CHEBI:7563

subject_name: N-nicotinoylglycine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:7563

object_name: obesity


subject: CHEBI:7563

object_name: Obesity, CTCAE


subject: MESH:D009539

subject_name: Nicotinic Acids


subject: MESH:D009539


subject: MESH:D009539


subject: UMLS:C3714626

subject_name: Nicotinic Acid Drug Class


subject: UMLS:C3714626


subject: UMLS:C3714626


subject: UMLS:C3536880

subject_name: Nicotinic Acid [EPC]


subject: UMLS:C3536880


subject: UMLS:C3536880


subject: PUBCHEM.COMPOUND:21628493

subject_name: ESTROGEN

object_name: Alzheimer disease type 1


subject: CHEBI:50114

subject_name: estrogen


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: UMLS:C2936882

subject_name: Estrogen [EPC]


subject: UNII:7DR7JMB8BH

object_name: tumor suppressor gene on chromosome 11


subject: UNII:7DR7JMB8BH

object_name: lung cancer


subject: UNII:SMA5ZS5B22

subject_name: Ensartinib


subject: UNII:SMA5ZS5B22


subject: CHEBI:45783

subject_name: Imatinib

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:45783

object_name: recurrent gastric cancer


subject: UMLS:C3272416

subject_name: PSMA-targeted Docetaxel Nanoparticles BIND-014

object_name: castration-resistant prostate carcinoma


subject: UMLS:C3272416

object_name: prostate carcinoma


subject: UMLS:C3272416

object_name: prostate cancer


subject: UNII:2S27T3DSZ3

object_name: diabetic kidney disease


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: ankylosing spondylitis


subject: UMLS:C0378942


subject: PUBCHEM.COMPOUND:135537060

subject_name: Rintatolimod

object_name: HER2 positive breast carcinoma


subject: PUBCHEM.COMPOUND:135537060

object_name: male breast carcinoma


subject: PUBCHEM.COMPOUND:135537060

object_name: Breast cancer stage II


subject: PUBCHEM.COMPOUND:135537060

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:135537060

object_name: Stage IIIB Breast Carcinoma


subject: PUBCHEM.COMPOUND:135537060

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Stage IIIA Breast Carcinoma


subject: PUBCHEM.COMPOUND:135537060

object_name: Stage IIIC Breast Cancer AJCC v6


subject: PUBCHEM.COMPOUND:135537060

object_name: Stage IIIC Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:135537060

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:135537060

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:135537060

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Breast cancer recurrent


subject: UNII:94325AJ25N

subject_name: RINTATOLIMOD

object_name: HER2 positive breast carcinoma


subject: UNII:94325AJ25N

object_name: male breast carcinoma


subject: UNII:94325AJ25N

object_name: Breast cancer stage II


subject: UNII:94325AJ25N

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UNII:94325AJ25N

object_name: Stage IIIB Breast Carcinoma


subject: UNII:94325AJ25N

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Stage IIIA Breast Carcinoma


subject: UNII:94325AJ25N

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UNII:94325AJ25N

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UNII:94325AJ25N

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:94325AJ25N

object_name: Carcinoma breast stage IV


subject: UNII:94325AJ25N

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Breast cancer recurrent


subject: CHEBI:22586

subject_name: antioxidant


subject: UMLS:C0003402

subject_name: Antioxidants


subject: CHEBI:44915

subject_name: Propofol

object_name: Intra-Abdominal Hypertension


subject: MESH:C579023

subject_name: AndoSan

object_name: allergic asthma


subject: MESH:C579023

object_name: Allergic rhinoconjunctivitis


subject: MESH:C579023

object_name: Immune Tolerance


subject: UMLS:C3899995

subject_name: Autologous NY-ESO-1-specific CD8-positive T Lymphocytes

object_name: malignant soft tissue neoplasm


subject: UMLS:C3899995

object_name: sarcoma


subject: CHEBI:32181

subject_name: Tamibarotene

object_name: tropical spastic paraparesis


subject: UMLS:C3859612

subject_name: Hyqvia

object_name: stiff-person syndrome


subject: MESH:C557698

subject_name: QMix root canal irrigant

object_name: Root canal infection


subject: MESH:C557698

object_name: dental pulp disorder


subject: UMLS:C5392699

object_name: essential hypertension


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Perioperative complication


subject: CHEBI:6888

object_name: arthroplasty; complications


subject: CHEBI:8988

object_name: Colon Neoplasm


subject: CHEBI:80630

subject_name: Irinotecan


subject: UMLS:C1515426

subject_name: Zadaxin

object_name: chronic hepatitis B virus infection


subject: UMLS:C5666851

object_name: dedifferentiated liposarcoma


subject: CHEBI:33313

subject_name: polonium atom

object_name: Postoperative urinary incontinence


subject: UMLS:C2984025

subject_name: Ferinject

object_name: Iron absorption level


subject: UMLS:C2609610

subject_name: ATryn

object_name: preeclampsia


subject: PUBCHEM.COMPOUND:10016910

object_name: cancer


subject: PUBCHEM.COMPOUND:10016910

object_name: neoplasm


subject: PUBCHEM.COMPOUND:10016910

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:10016910

object_name: lymphoma


subject: PUBCHEM.COMPOUND:10016910

object_name: pediatric lymphoma


subject: UMLS:C1831757


subject: UMLS:C1831757


subject: UMLS:C1831757


subject: UMLS:C1831757


subject: UMLS:C1831757


subject: PUBCHEM.COMPOUND:78140854

subject_name: Ivosidenib

object_name: recurrent adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:78140854

object_name: recurrent childhood acute myeloid leukemia


subject: UMLS:C3827169

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C3827169


subject: UMLS:C3827169


subject: UNII:2WWN8F640E

object_name: cystic fibrosis


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: cardiovascular disorder


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:74855

subject_name: Thr-Gln

object_name: gingivitis


subject: UNII:ZO763K43XR

subject_name: TOCOQUINONE


subject: CHEBI:113532

subject_name: Thymoquinone


subject: UMLS:C0972569

subject_name: Electrophoresis Gel


subject: UMLS:C1382104

subject_name: Gel physical state


subject: UMLS:C1551386

subject_name: Gel - ContainerSeparator


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: female infertility


subject: CHEBI:39867

subject_name: Valproic acid

object_name: Body Composition


subject: CHEBI:39867

object_name: type 2 diabetes mellitus


subject: CHEBI:39867

object_name: Insulin resistance


subject: CHEBI:60654

subject_name: valproate


subject: CHEBI:60654


subject: CHEBI:60654


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:601027

subject_name: Aliskiren

object_name: Hypertensive left ventricular hypertrophy


subject: CHEBI:31547

subject_name: Eplerenone


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: pulmonary fibrosis


subject: CHEBI:73604

object_name: Pulmonary Fibrosis, CTCAE


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: Zollinger-Ellison syndrome


subject: CHEBI:6375

object_name: multiple endocrine neoplasia


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: Inflammation


subject: UNII:B72HH48FLU

object_name: major depressive disorder


subject: CHEBI:177783

subject_name: Eniluracil

object_name: colorectal carcinoma


subject: CHEBI:177783

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: sinusitis


subject: CHEBI:60648

object_name: Sinusitis, CTCAE


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: CHEMBL.COMPOUND:CHEMBL4650410

subject_name: NOVAFERON

object_name: metastatic colorectal cancer


subject: UMLS:C3273450

subject_name: Novaferon


subject: CHEBI:27470

subject_name: Folic acid

object_name: Stomach cancer


subject: CHEBI:27470

object_name: gastric cancer


subject: CHEBI:27470


subject: CHEBI:133146

subject_name: Phe-Ala


subject: CHEBI:133146


subject: CHEBI:133146


subject: CHEBI:39002

subject_name: perfluoroadamantane


subject: CHEBI:39002


subject: CHEBI:39002


subject: CHEBI:29013

subject_name: Fusidic acid


subject: CHEBI:29013


subject: CHEBI:29013


subject: UNII:AF75XOF6W3

subject_name: Relatlimab


subject: UMLS:C3827149


subject: CHEBI:17596

subject_name: Inosine

object_name: wet macular degeneration


subject: CHEBI:17596

object_name: diabetic macular edema


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:27013

subject_name: Tocopherol


subject: CHEBI:27013


subject: CHEBI:197268

subject_name: Tocotrienol


subject: CHEBI:197268


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:17154


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline


subject: CHEBI:91435

subject_name: Linifanib

object_name: Advanced renal cell carcinoma


subject: UMLS:C1738762

subject_name: ABT 869


subject: CHEBI:58779

object_name: Substance Use Disorders


subject: CHEBI:49086


subject: CHEBI:16436

subject_name: Citicoline


subject: UMLS:C4329513

object_name: metastatic neoplasm


subject: UMLS:C4329513

object_name: Metastatic Lesion


subject: UMLS:C4329513

object_name: HER2 low breast cancer


subject: UMLS:C4329513

object_name: progesterone-receptor positive breast cancer


subject: UMLS:C4329513

object_name: estrogen-receptor positive breast cancer


subject: UMLS:C4329513

object_name: Her2-receptor negative breast cancer


subject: UMLS:C4329513

object_name: HER2 positive breast carcinoma


subject: UMLS:C4329513

object_name: triple-negative breast carcinoma


subject: UMLS:C4329513

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C4329513

object_name: hormone receptor-positive breast cancer


subject: UMLS:C4329513

object_name: HER2-Low Breast Carcinoma


subject: UMLS:C4329513

object_name: Hormone Receptor-Negative Breast Carcinoma


subject: UMLS:C4329513

object_name: HER2 protein overexpression


subject: UMLS:C4329513

object_name: ERBB2 mutation-related tumors


subject: UMLS:C4329513

object_name: Estrogen receptor positive tumor


subject: UMLS:C4329513

object_name: Solid carcinoma


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766

object_name: Adult Solid Neoplasm


subject: UMLS:C4287766


subject: UMLS:C4287766

object_name: Childhood Solid Neoplasm


subject: UMLS:C4287766

object_name: Solid Neoplasm


subject: UNII:234248D0HH

subject_name: Tucatinib

object_name: metastatic neoplasm


subject: UNII:234248D0HH

object_name: Metastatic Lesion


subject: UNII:234248D0HH

object_name: Disseminated Malignant Neoplasm


subject: UNII:234248D0HH

object_name: Embolism, Tumor


subject: UNII:234248D0HH

object_name: Neoplasm Metastasis


subject: UNII:234248D0HH

object_name: HER2 low breast cancer


subject: UNII:234248D0HH

object_name: progesterone-receptor positive breast cancer


subject: UNII:234248D0HH

object_name: estrogen-receptor positive breast cancer


subject: UNII:234248D0HH

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:234248D0HH

object_name: hormone receptor-positive breast cancer


subject: UNII:234248D0HH

object_name: HER2-Low Breast Carcinoma


subject: UNII:234248D0HH

object_name: Hormone Receptor-Negative Breast Carcinoma


subject: UNII:234248D0HH

object_name: HER2 protein overexpression


subject: UNII:234248D0HH

object_name: ERBB2 mutation-related tumors


subject: UNII:234248D0HH

object_name: Estrogen receptor positive tumor


subject: UNII:234248D0HH

object_name: Adult Solid Neoplasm


subject: UNII:234248D0HH

object_name: Solid carcinoma


subject: UNII:234248D0HH

object_name: Childhood Solid Neoplasm


subject: UNII:234248D0HH

object_name: Solid Neoplasm


subject: GTOPDB:13627

subject_name: zanidatamab

object_name: metastatic neoplasm


subject: GTOPDB:13627

object_name: Metastatic Lesion


subject: GTOPDB:13627

object_name: Carcinoma breast stage IV


subject: GTOPDB:13627

object_name: Disseminated Malignant Neoplasm


subject: GTOPDB:13627

object_name: Embolism, Tumor


subject: GTOPDB:13627

object_name: Neoplasm Metastasis


subject: GTOPDB:13627

object_name: HER2 low breast cancer


subject: GTOPDB:13627

object_name: progesterone-receptor positive breast cancer


subject: GTOPDB:13627

object_name: estrogen-receptor positive breast cancer


subject: GTOPDB:13627

object_name: Triple-Negative Breast Cancer Finding


subject: GTOPDB:13627

object_name: hormone receptor-positive breast cancer


subject: GTOPDB:13627

object_name: HER2-Low Breast Carcinoma


subject: GTOPDB:13627

object_name: Hormone Receptor-Negative Breast Carcinoma


subject: GTOPDB:13627

object_name: ERBB2 mutation-related tumors


subject: GTOPDB:13627

object_name: Estrogen receptor positive tumor


subject: GTOPDB:13627

object_name: Adult Solid Neoplasm


subject: GTOPDB:13627

object_name: Solid carcinoma


subject: GTOPDB:13627

object_name: Childhood Solid Neoplasm


subject: GTOPDB:13627

object_name: Solid Neoplasm


subject: UNII:Z20OC92TDI

subject_name: ZANIDATAMAB

object_name: metastatic neoplasm